JP2024511799A5 - - Google Patents
Info
- Publication number
- JP2024511799A5 JP2024511799A5 JP2023559016A JP2023559016A JP2024511799A5 JP 2024511799 A5 JP2024511799 A5 JP 2024511799A5 JP 2023559016 A JP2023559016 A JP 2023559016A JP 2023559016 A JP2023559016 A JP 2023559016A JP 2024511799 A5 JP2024511799 A5 JP 2024511799A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- peptide
- mutations
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163166697P | 2021-03-26 | 2021-03-26 | |
| US63/166,697 | 2021-03-26 | ||
| PCT/US2022/022074 WO2022204583A1 (en) | 2021-03-26 | 2022-03-26 | Methods and compounds for neoantigen vaccines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024511799A JP2024511799A (ja) | 2024-03-15 |
| JP2024511799A5 true JP2024511799A5 (https=) | 2025-04-02 |
Family
ID=83397965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023559016A Pending JP2024511799A (ja) | 2021-03-26 | 2022-03-26 | ネオアンチゲンワクチンのための方法および化合物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240240259A1 (https=) |
| EP (1) | EP4313129A4 (https=) |
| JP (1) | JP2024511799A (https=) |
| KR (1) | KR20230162677A (https=) |
| CN (1) | CN117479951A (https=) |
| AU (1) | AU2022245391A1 (https=) |
| CA (1) | CA3212877A1 (https=) |
| WO (1) | WO2022204583A1 (https=) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2569633B1 (en) * | 2010-05-14 | 2016-02-10 | The General Hospital Corporation | Compositions and methods of identifying tumor specific neoantigens |
| EP3892295B1 (en) * | 2011-05-24 | 2023-04-26 | BioNTech SE | Individualized vaccines for cancer |
| EP3736573A1 (en) * | 2013-03-15 | 2020-11-11 | Prognosys Biosciences, Inc. | Methods for detecting peptide/mhc/tcr binding |
| BR112019015797A2 (pt) * | 2017-02-01 | 2020-03-17 | Modernatx, Inc. | Composições de mrna terapêuticas imunomoduladoras que codificam peptídeos de mutação de oncogene de ativação |
| EP3918069A1 (en) * | 2019-01-31 | 2021-12-08 | Bar Ilan University | Neoantigens created by aberrant-induced splicing and uses thereof in enhancing immunotherapy |
-
2022
- 2022-03-26 AU AU2022245391A patent/AU2022245391A1/en active Pending
- 2022-03-26 CN CN202280037941.5A patent/CN117479951A/zh active Pending
- 2022-03-26 US US18/551,356 patent/US20240240259A1/en active Pending
- 2022-03-26 EP EP22776775.3A patent/EP4313129A4/en active Pending
- 2022-03-26 JP JP2023559016A patent/JP2024511799A/ja active Pending
- 2022-03-26 KR KR1020237036982A patent/KR20230162677A/ko active Pending
- 2022-03-26 WO PCT/US2022/022074 patent/WO2022204583A1/en not_active Ceased
- 2022-03-26 CA CA3212877A patent/CA3212877A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2080812A1 (en) | Compositions and methods of detecting post-stop peptides | |
| EP2872653B1 (en) | Personalized cancer vaccines and adoptive immune cell therapies | |
| US20180045735A1 (en) | Methods and Compositions For The Diagnosis And Treatment Of Cancer and Autoimmune Disorders | |
| CA2658305C (en) | Transcription infidelity, detection and uses thereof | |
| US20070161001A1 (en) | Quantifying and profiling antibody and t cell receptor gene expression | |
| WO2003026493A2 (en) | Diagnosis and treatment of diseases caused by mutations in cd72 | |
| CN121963858A (zh) | 新生抗原分析 | |
| ES2402095T3 (es) | Genes y productos de expresión génica que son regulados en forma diferencial en el cáncer de próstata | |
| WO2001042277A2 (en) | Complementary peptide ligands generated from the human genome | |
| CN113355332B (zh) | Heg1基因突变体及其应用 | |
| JP2024511799A5 (https=) | ||
| Hawkins | Analysis of human genetic variations using DNA sequencing | |
| Yin et al. | Next-generation sequencing technologies accelerate advances in T-cell therapy for cancer | |
| JP2005529618A (ja) | Ａｂｃｇ２多型による薬物輸送能の予測方法 | |
| Chandran et al. | Immunogenicity of a public neoantigen derived from mutated PIK3CA | |
| CN117999350A (zh) | 一种t细胞表位序列的鉴定方法及其应用 | |
| JP2005531290A5 (https=) | ||
| WO2026032432A1 (zh) | 纳米孔-核酸聚合酶的双位点偶联 | |
| US20240379186A1 (en) | Method to generate personalized neoantigens of a tumor of a patient | |
| Semente et al. | Bionformatic neoantigens prediction from Next generation sequencing data | |
| Certa et al. | Focal Point: Biotechnology: Technologies for Genome Analysis: Applications in Biomedical Research | |
| Huo et al. | Genome survey of adlay (Coix lachryma-jobi L.) by next generation sequencing: development of novel SSR markers and genetic diversity in Coix species | |
| US20170275683A1 (en) | Method for High-Throughput, Ultra Long-Read DNA Sequencing | |
| WO2005005647A2 (en) | Compositions, splice variants and methods relating to ovarian specific genes and proteins | |
| EA010352B1 (ru) | Способ дифференциального анализа протеомов |